Brian E. Schultz

Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

Zhengying Pan, Heleen Scheerens, Shyr‐Jiann Li et al. · ChemMedChem · 2006 · 669 citations

Rheumatoid Disorder, Molecular Pharmacology, Medicinal Chemistry +14

Molybdenum-mediated oxygen-atom transfer: an improved analog reaction system of the molybdenum oxotransferases

Brian E. Schultz, Stephen F. Gheller, Mark C. Muetterties et al. · Journal of the American Chemical Society · 1993 · 156 citations

Oxygen Reduction Reaction, Molecular Sciences, Biosynthesis +15

Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ

John R. Somoza, David Koditek, Armando G. Villaseñor et al. · Journal of Biological Chemistry · 2015 · 153 citations · Full text

Molecular Pharmacology, Biophysical Characterization, Proteinlipid Interaction +12

ASK1 contributes to fibrosis and dysfunction in models of kidney disease

John T. Liles, Britton K. Corkey, Gregory T. Notte et al. · Journal of Clinical Investigation · 2018 · 137 citations · Full text

CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity <i>in vitro</i> and <i>in vivo</i>

Joseph J. Buggy, Zhe Cao, Kathryn E. Bass et al. · Molecular Cancer Therapeutics · 2006 · 124 citations · Full text

Histone Modifications, Antitumor Activity, Novel Hdac Inhibitor +20